The Effect of COVID-19 on Type 1 Diabetes Occurrence among Children and Adolescents: A Multicenter Prospective Observational Cohort Study in Israel

Figure 1

Quantification of neutralizing antibodies among unvaccinated children. Quantitation of neutralizing antibodies is shown among children who did not receive the BNT162b2 vaccine for children with type 1 diabetes (T1D) and matched controls. Neutralizing antibodies that were above the cutoff are presented. The dotted black line indicates the limit level of positive antibodies. The short black line indicates the geometric means and 95% CI.